¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"virilizing adrenal carcinoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
¿µ¹® carcinoma in situ ÇÑ±Û »óÇdz»¾ÏÁ¾
¼³¸í   
  ½ÅüÀÇ ³»ºÎ³ª ¿ÜºÎ¸¦ ½×°í Àִ Á¶Á÷À» »óÇǶó°í ÇÑ´Ù. ÀÌ »óÇÇÀÇ ¾Æ·¡¿¡´Â ´ë°³ »óÇǸ¦ ÁöÁöÇϰí Àִ Á¶Á÷ÀÇ À§¿¡ Á¸ÀçÇÑ´Ù. ±×¸®°í ÀÌ ÁöÁöÁ¶Á÷°ú »óÇÇ »çÀÌ¿¡´Â ±âÀú¸·À̶ó´Â ¸·ÀÌ À־ »óÇǿ͠ÁöÁöÁ¶Á÷À» ±¸ºÐÇØ ÁØ´Ù. ¾ÏÁ¾(carcinoma)¶õ »óÇÇÀÇ ¼¼Æ÷°¡ ¾Ç¼º º¯È­¸¦ ÇÏ¿© »ý±â´Â ¾ÏÀ» ¸»ÇÑ´Ù. Á¦ÀÚ¸®¾ÏÁ¾À̶õ ¾ÏÁ¾ÀÇ ÇÑ Á¾·ù·Î ¾ÏÁ¾ÀÌ ±âÀú¸·À» ¹þ¾î³ªÁö ¸øÇÏ°í »óÇdz» Áï, Á¦ÀÚ¸®¿¡ ¸Ó¹°·¯ Àִ °æ¿ì¸¦ ¸»ÇÑ´Ù.
¿µ¹® carcinoma ÇÑ±Û ¾ÏÁ¾
¼³¸í   
  ¾ÏÁ¾À̶õ »óÇǼ¼Æ÷(-½ÅüÀÇ ³»ºÎ³ª ¿ÜºÎ¸¦ ½×°í Àִ Á¶Á÷À» »óÇǶó°í Çϰí, »óÇǸ¦ ÀÌ·ç°í Àִ ¼¼Æ÷¸¦ »óÇǼ¼Æ÷¶ó°í ÇÑ´Ù)ÀÇ °úµµÇÑ Áõ½Ä¿¡ÀÇÇÑ ¾Ç¼ºÁ¾¾çÀ» À̸£´Â ¸»ÀÌ´Ù.
¿µ¹® renal cell carcinoma ÇÑ±Û ÄáÆÏ¼¼Æ÷¾ÏÁ¾
¼³¸í   
  ÄáÆÏ¿¡ »ý±ä ¿ø½ÃÄáÆÏÁ¶Á÷¿¡¼­ ¹ß»ýÇÑ ¾Ï. ÁַΠ¿ø½Ã¼¼´¢°üÁ¶Á÷¿¡¼­ ¹ß»ýÇÑ´Ù. ´ëÇ¥ÀûÀΠ¼¼Æ÷Á¶Á÷ÇüÀº ¿°»ö½Ã ¼¼Æ÷ÁúÀÌ ¸¼°Ô ºñ¾îº¸À̴ ¸¼Àº¼¼Æ÷¾ÏÁ¾ÀÌ´Ù. Ä¡·á´Â ¼ö¼ú°ú Ç×¾ÏÈ­Çпä¹ýÀ̸砾ÆÁÖ µå¹°Áö¸¸ ÀúÀý·Î ³´´Â °æ¿ìµµ Àִ °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ´Ù.
¿µ¹® squamous cell carcinoma ÇÑ±Û ÆíÆò¼¼Æ÷¾ÏÁ¾
¼³¸í   
  ÆíÆò¼¼Æ÷ ±â¿øÀÇ ¾ÏÀ¸·Î¼­, ÆíÆò¼¼Æ÷°¡ Àִ ¾î¶² °÷¿¡¼­µç ¹ß»ý°¡´ÉÇÔ. µû¶ó¼­ ½Äµµ¾Ï, ÇǺξÏ, Æó¾Ï, ÀڱþϠµîÀÌ ¿©±â¿¡ ÇØ´çµÈ´Ù. Æ¯È÷ ÇǺξÏÀº ¸¹Àº Àڿܼ±Á¶»ç¿¡ ÀÇÇØ »ý±â´Â ±¤¼±°¢È­Áõ¿¡¼­ ¹ß»ý°¡´ÉÇÏ´Ù. º´¸®Á¶Á÷ÇÐÀû Æ¯¼ºÀ¸·Î¼­ °¢ÁúÀ» »ý¼ºÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • congenital adrenal hyperplasia
    ¼±ÃµºÎ½Å°ú´ÙÇü¼º, ¼±ÃµÄáÆÏÀ§»ù°ú´ÙÇü¼º
  • hypothalamic-pituitary-adrenal axis
    ½Ã»óÇϺÎ-³úÇϼöü-ºÎ½ÅÃà
  • lipoid adrenal hyperplasia
    ÁöÁúºÎ½Å°ú´ÙÇü¼º
  • apocrine carcinoma
    ¾ÆÆ÷Å©¸°¾ÏÁ¾
  • acinar cell carcinoma
    »ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
  • acinic cell carcinoma
    »ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
  • adenocystic carcinoma
    »ù³¶¾ÏÁ¾, ¼±³¶¾ÏÁ¾
  • adenoid cystic carcinoma
    »ù³¶¾ÏÁ¾, ¼±³¶¾ÏÁ¾
  • adenoma-carcinoma sequence
    »ùÁ¾¾ÏÁ¾¿¬¼â, ¼±Á¾¾ÏÁ¾¿¬¼â
  • adnexal carcinoma
    ºÎ¼Ó±â°ü¾ÏÁ¾
  • anaplastic carcinoma
    ¿ªÇü¼º¾ÏÁ¾
  • basal cell carcinoma
    ¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
  • basosquamous cell carcinoma
    ¹Ù´ÚÆíÆò¼¼Æ÷¾ÏÁ¾, ±âÀúÆíÆò¼¼Æ÷¾ÏÁ¾
  • bronchioloalveolar carcinoma
    ¼¼±â°üÁöÆóÆ÷¾ÏÁ¾, ¼¼±â°üÁö²Ê¸®¾ÏÁ¾
  • bronchoalveolar carcinoma
    ±â°üÁöÆóÆ÷¾ÏÁ¾
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • papillary thyroid carcinoma
    À¯µÎ°©»ó»ù¾ÏÁ¾
  • signet ring cell carcinoma
    ¹ÝÁö¼¼Æ÷¾ÏÁ¾
  • small cell carcinoma
    ¼Ò¼¼Æ÷¾ÏÁ¾
  • squamous cell carcinoma
    ÆíÆò¼¼Æ÷¾ÏÁ¾
  • squamous cell in situ carcinoma
    ÆíÆò¼¼Æ÷»óÇdz»¾ÏÁ¾, ÆíÆò¼¼Æ÷¾ÏÁ¾
  • transitional cell carcinoma
    ÀÌÇ༼Æ÷¾ÏÁ¾
  • tubular carcinoma
    °ü¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • androgenic adrenal hyperplasia
    ¾Èµå·Î°ÕºÎ½Å°ú´ÙÇü¼º
  • lipoid adrenal hyperplasia
    ÁöÁúºÎ½Å°ú´ÙÇü¼º
  • acinar carcinoma
    »ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
  • acinic cell carcinoma
    »ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
  • adenocystic carcinoma
    (¢¡adenoid cystic carcinoma) »ù³¶¾ÏÁ¾
  • adenoid cystic carcinoma
    »ù³¶¾ÏÁ¾
  • adenoma-carcinoma sequence
    »ùÁ¾¾ÏÁ¾¼ø¼­
  • adnexal carcinoma
    ºÎ¼Ó±â°ü¾ÏÁ¾
  • apocrine gland carcinoma
    ¾ÆÆ÷Å©¸°¶¡»ù¾ÏÁ¾
  • arsenical carcinoma
    ºñ¼Ò¾ÏÁ¾
  • basal cell carcinoma
    ¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
  • basosquamous cell carcinoma
    ¹Ù´ÚÆíÆò¼¼Æ÷¾ÏÁ¾, ±âÀúÆíÆò¼¼Æ÷¾ÏÁ¾
  • bronchioloalveolar carcinoma
    ¼¼±â°üÁöÆóÆ÷¾ÏÁ¾, ¼¼±â°üÁö²Ê¸®¾ÏÁ¾
  • bronchogenic carcinoma
    ±â°üÁöÀ¯·¡¾ÏÁ¾
  • carcinoma
    ¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • giant cell carcinoma
    °Å¼¼Æ÷¾ÏÁ¾
  • glandular carcinoma
    ¼±¾ÏÁ¾(¼±¾ÏÁ¾).
  • glassy cell carcinoma of cervix
    À¯¸®¾ç ¼¼Æ÷ ÀڱðæºÎ¾Ï
  • granular basal cell carcinoma
    °ú¸³ ±âÀú¼¼Æ÷¾Ï
  • granulosa cell carcinoma
    (³­¼Ò)°ú¸³¸·¼¼Æ÷ ¾ÏÁ¾(Õ°áµÎ¨í£Ø¯á¬øà ðþ).
  • hepatocellular carcinoma
    °£¼¼Æ÷¼º ¾Ï
  • hepatocellular carcinoma
    °£¼¼Æ÷¾ÏÁ¾(ÊÜá¬øàäßðþ)
  • pigmented basal cell carcinoma
    »ö¼ÒÄ§Âø ±âÀú¼¼Æ÷¾Ï
  • pilomatrix carcinoma
    ¸ð¹ß±âÁú ¾Ï(Á¾)
  • postcricoid carcinoma
    ÈÄÀ±(»ó)¾ÏÁ¾
  • primary bronchogenic carcinoma
    ¿ø¹ß(¼º)±â°üÁö¾Ï
  • primary carcinoma
    ¿ø¹ß¾ÏÁ¾(ê«Û¡äßðþ)
  • primary cutaneous adenocystic carcinoma
    ¿ø¹ß¼º ÇǺΠ¼±³¶Á¾¼º¾Ï
  • primary hepatic carcinoma
    ¿ø¹ß(¼º) °£¾ÏÁ¾(ê«Û¡(àõ) ÊÜäßðþ)
  • prostate carcinoma
    Àü¸³¼±¾ÏÁ¾(îñí¡àÍäßðþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • adrenal cortex,aldosterone secretion
    ¾Ëµµ½ºÅ׷ккñ(¡­ÝÂÝô)
  • adrenal cortex,cushings syndrome
    Äí½ÌÁõÈıº(¡­ñøý¦ÏØ)
  • adrenal cortex,hyperfunction
    ±â´ÉÇ×Áø(ÐüÒöùñòä)
  • adrenal cortex,hypofunction
    ±â´ÉÀúÇÏ(ÐüÒöî¸ù»)
  • adrenal cortical hormone =adrenocortical hormone
    ºÎ½ÅÇÇÁúÈ£¸£¸ó
  • adrenal cortical insufficiency
    ºÎ½ÅÇÇÁú(±â´É)ºÎÀü(Áõ).
  • adrenal corticosteroid
    ºÎ½ÅÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å.
  • adrenal corticosteroid
    ºÎ½ÅÇÇÁú½ºÅ×·ÎÀ̵å
  • adrenal corticotropic hormone =ACTH
    ºÎ½ÅÇÇÁúÀÚ±Ø(¡­ô§Ð½)È£¸£¸ó
  • adrenal crisis
    ºÎ½Å¼º À§±â(¹ßÁõ)
  • adrenal crisis
    ºÎ½Å(±Þ¼º)¹ßÁõ(¡­ÐáàõÛ¡ñø). ´ç´¢ ºÎ½Å¼º À§±â.
  • adrenal cyst
    ºÎ½Å³¶Á¾
  • adrenal disorders
    ºÎ½ÅÀå¾Ö, ºÎ½ÅÁúȯ.
  • adrenal feminism
    ºÎ½Å¼º ¿©¼ºÈ­Áõ(¡­åüàõûùñø).
  • adrenal feminization
    ºÎ½Å(¼º) ¿©¼ºÈ­(¡­åüàõûù).
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pancreatic carcinoma
    ÃéÀå¾ÏÁ¾
  • squamous cell carcinoma
    ÆíÆò¼¼Æ÷¾ÏÁ¾
  • undifferentiated carcinoma
    ¹ÌºÐÈ­¾ÏÁ¾
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SCC self-care center; sequential combination chemotherapy; services for crippled children; short-course ...
CAH   1) Chronic Active Hepatitis
  2) Congenital Adrenal Hyperplasia
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
HPA axis Hypothalamic-Pituitary-Adrenal axis
AA abdominal aorta; acetic acid; achievement age; active alcoholic; active assistive [range of motion];...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CAH Cogenital adrenal hyperplasia
HPA Hypothalamic-Pituitary-Adrenal
HPA Hypothalamic-pituitary-adrenal axis
HPA Hypothalamo-pituitary--adrenal
HPA Hypothalamus-pituitary-adrenal
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • adrenal glucocorticoid
    ºÎ½Å ±Û·çÄÚÄÚÆ¼ÄÚÀ̵å
  • adrenal hyperplasia
    ºÎ½Å °úÇü¼º
  • adrenal insufficiency
    ºÎ½Å ºÎÀü, ºÎ½Å ±â´ÉºÎÀü, ºÎ½Å±â´É ºÎÀüÁõ
    1. ºÎ½Å±â´ÉÀÇ ºñÁ¤»óÀû ÀúÇÏ. ¿¹ÄÁ´ë ¿¡µð½¼º´¿¡¼­ º¼ ¼ö ÀÖ´Ù. 2. ±Þ¼º ¶Ç´Â ¸¸¼º ÁõÈıºÀ¸·Î¼­ ³ªÅ¸³ª¸ç ÁÖµÈ Æ¯Â¡Àº ÀúÇ÷¾ÐÀ̸ç, ÀϹÝÀûÀÎ Áõ»óÀº ¼è¾à, üÁß°¨¼Ò, ¿À½É, ±¸Åä µîÀÌ´Ù. ½ºÅ×·ÎÀ̵å Á¦À縦 Àå±â°£ Åõ¿© ¹Þ¾Æ¿Â ȯÀÚµéÀº Ä¡°ú ½Ã¼úÀ̳ª Á¤½ÅÀû ½ºÆ®·¹½º¿¡ ÀÇÇØ ÀÀ±Þ »çŰ¡ ¹ß»ýÇÒ ¼ö ÀÖ´Ù. ÃÖ¼±ÀÇ Ä¡·á´Â ¿¹¹æÀε¥ Ä¡·á ¾à¼Ó Àü¿¡ ´ã´çÀÇ»ç¿Í »óÀÇÇÏ¿© ½ºÅ×·ÎÀ̵å Á¦À縦 ºÎ°¡ÀûÀ¸·Î Åõ¿©ÇÑ ÈÄ ½Ã¼úÇÏ¿©¾ß ÇÑ´Ù.
  • adrenal medullary chromaffin cell
    ºÎ½Å ¼öÁú Å©·Ò ģȭ ¼¼Æ÷
  • adrenal steroid
    ºÎ½Å ½ºÅ×·ÎÀ̵å
  • adrenal suppressive effect
    ºÎ½Å ¾ïÁ¦ È¿°ú
  • adrenal tuberculosis
    ºÎ½Å °áÇÙ, ºÎ½Å °áÇÙÁõ
  • adrenal vein
    ºÎ½Å Á¤¸Æ
  • chronic insufficiency of adrenal cortex
    ºÎ½Å ÇÇÁúÀÇ ¸¸¼º ºÎÀü
    ÇǺΰ¡ °¥»öÀ» ¶ì°Ô µÈ´Ù. Á¡¸·¿¡ »ö¼Ò°¡ Ä§ÂøÇÑ´Ù. ¾àÇÑ ½ÉÀåÀÇ È°µ¿, ¹«±â·ÂÁõ, ¼³»ç, ±¸Åä, ºóÇ÷.
  • hypoplasia of adrenal gland
    ºÎ½Å¼± ¹ßÀ° ºÎÀü
  • normal adrenal function
    Á¤»óÀûÀÎ ºÎ½Å ±â´É
  • pituitary adrenal system
    Çϼöü ºÎ½Å ÇÇÁú°è
  • salt-losing adrenal hyperplasia
    ¿°·ù ¼Ò½Ç¼º ºÎ½Å Áõ½ÄÁõ
  • acinar carcinoma
    ¼±¹æ ¾ÏÁ¾
    ÃéÀå ¾ÏÁ¾ Áß µå¹°°Ô ¾ÏÁ¾ÀÌ ¼±¹æ¼¼Æ÷¿¡¼­ ¹ß»ýÇÏ´Â °Í. À̵é Á¾¾çÀº Á¾¾ç ¼¼Æ÷µéÀÌ ¶×¶×ÇÏ°í ´Ù°¢ÇüÀ̸ç È£»ê¼º ¼Ò°ßÀ» º¸ÀÌ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù.
  • acinic cell carcinoma
    ¼±¹æ ¼¼Æ÷ ¾ÏÁ¾
    1. ¼±¹æ ¼¼Æ÷, ±Ù»óÇǼ¼Æ÷°¡ Áõ½ÄÇÏ¿© Çü¼ºµÇ°í ³·Àº ¾Ç¼ºµµ¸¦ º¸ÀδÙ. 2. Ÿ¾×¼± ¾à¼º Á¾¾ç Áß 5¹øÂ°ÀÇ ¹ß»ý ºñÀ²À» °®´Â Á¾¾çÀ¸·Î 90%¿¡¼­ ÀÌÇϼ±¿¡¼­ ¹ß»ýÇÏ¸ç ¾ÇÇϼ±°ú ¼ÒŸ¾×¼±¿¡¼­µµ µå¹°°Ô ¹ß»ýÇÑ´Ù. ¿©¼º¿¡¼­ ´Ù¼Ò È£¹ßÇϰí, ¾î´À ¿¬·É¿¡¼­³ª ¹ß»ýÇϳª ÁÖ·Î 30-70´ë¿¡ °ñ°í·ç ¹ß»ýÇÑ´Ù. ¿¹Àü¿¡´Â ¾ç¼ºÀ¸·Î »ý°¢ÇÏ¿© ¼±¹æ¼¼Æ÷Á¾À̶ó ºÎ¸¥ ÀûÀÌ ÀÖÀ¸³ª ºÐ¸íÇÑ ¾Ç¼ºÀ¸·Î ¼±¾ÏÁ¾À¸·Î ºÎ¸¥´Ù. Á¾¾ç ¼¼Æ÷´Â Àå¾×¼º ¼±¹æ¼¼Æ÷¿Í À¯»çÇÏÁö¸¸ ¿©·¯ °¡Áö ´Ù¸¥ ¼¼Æ÷µéÀÌ ³ªÅ¸³ª¸ç, °³Á¦°ü ¿¹ºñ¼¼Æ÷¿¡¼­ ±â¿øÇÑ´Ù°í º»´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
adrenal capsule See adrenal gland.
(12 Dec 1998)
adrenal cortex <anatomy, endocrinology> This is the outer portion of the fattyacids and inhibit inflammation in allergic responses. Mineralocortoids regulate the levels of minerals such as sodium and potassium in the blood.
(06 May 1997)
adrenal cortex injection An obsolete treatment involving the parenteral administration of extract of the adrenal cortex; formerly used in treatment of Addison's disease.
(05 Mar 2000)
adrenal cortical carcinomas Large invasive and metastasizing tumours which may cause virilism or Cushing's syndrome.
(05 Mar 2000)
adrenal cortical syndrome <syndrome> An inexact (and obsolete) term that has been applied to Cushing's syndrome, Addison's disease, or the adrenogenital syndrome.
(05 Mar 2000)
adrenal crisis <endocrinology> An abrupt life-threatening state which is caused by insufficient production of cortisol by the adrenal gland. A typical finding in Addison's disease. Individuals who have been taking corticosteroids (glucocorticoids) for a prolonged period of time (weeks to months) are at risk for acute adrenal crisis if the medication is stopped abruptly. For this reason, corticosteroid medication are withdrawn slowly on a diminishing dosing schedule.
Symptoms include low blood pressure (shock), weakness, headache, vomiting, fever chills, tachycardia and sweating.
Treatment includes blood pressure support and intravenous hydrocortisone.
(27 Sep 1997)
adrenal cyst <radiology> Same characteristics as renal cysts, but less common, thick wall, septations, calcifications suggests pseudocyst
(12 Dec 1998)
adrenal gland <anatomy, endocrinology> This gland is found above each kidney and it made up of an outer wall (cortex) that secretes important steroid hormones and an inner portion (medulla) that produces adrenaline (adrenaline) and noradrenaline (noradrenaline).
The hormones help control heart rate, blood pressure, the way the body uses food, and other vital functions.
(25 Jun 1999)
adrenal gland hypofunction Adrenocortical hypofunction includes all conditions in which adrenal steroid hormone secretion falls below the requirements of the body. Adrenal insufficiency may be divided into two general categories: (1) those associated with primary inability of the adrenal to elaborate sufficient quantities of hormone and (2) those associated with a secondary failure due to a primary failure in the elaboration of adrenocorticotropin.
(12 Dec 1998)
adrenal gland insufficiency <endocrinology> A condition that results from the inadequate production of adrenal hormones (see Addison's disease).
(27 Sep 1997)
adrenal gland tumour <oncology> A benign tumour or adenoma, that usually results in the excess production of adrenal gland hormones.
(27 Sep 1997)
adrenal haemorrhage <radiology> Neonate, right more common, 10% bilateral, birth trauma, hypoxia, septicaemia, congenital syphilis, haemorrhagic disorders (haemophilia, etc.) adult, septicaemia (Waterhouse-Friderichsen syndrome), tumour, trauma Notes: usually resolves in 4-6 weeks, adrenal insufficiency rare, even if bilateral, may calcify
(12 Dec 1998)
adrenal hermaphroditism Altered appearance of the genitalia due to disorders of adrenocortical function, most often female virilization; not an example of true hermaphroditism.
(05 Mar 2000)
adrenal hyperplasia <pathology> A condition of diffuse enlargement of the adrenal glands.
Origin: Gr. Plassein = to form
(27 Sep 1997)
adrenal hyperplasia, congenital A group of inherited disorders of adrenal steroidogenesis, the physical expression of which varies with the sex of the patient, the severity of the congenital enzyme defect, and the age at which the defect makes its presence felt. The most common form, the simple virilizing form, is due to a 21-hydroxylase deficiency. There is also a salt-losing form (a more complete 21-hydroxylase deficiency), a hypertensive form (11-hydroxylase deficiency), a 17-hydroxylase deficiency form, a desmolase deficiency form, and a 3-beta-hydroxysteroid deficiency form.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á